A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome

MLA

Eugenio Torre, et al. “A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome.” Basic & Clinical Pharmacology & Toxicology, May 2012. EBSCOhost, https://doi.org/10.1111/j.1742-7843.2012.00896.x.

APA

Eugenio Torre, Cristina Nativi, Marco Fragai, Emanuele De Lorenzo, Mattia Mori, Claudio Luchinat, & Annarosa Arcangeli. (2012). A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/j.1742-7843.2012.00896.x

Chicago

Eugenio Torre, Cristina Nativi, Marco Fragai, Emanuele De Lorenzo, Mattia Mori, Claudio Luchinat, and Annarosa Arcangeli. 2012. “A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome.” Basic & Clinical Pharmacology & Toxicology, May. doi:10.1111/j.1742-7843.2012.00896.x.